![]() |
Volumn 4, Issue , 2013, Pages
|
Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZAMIDE DERIVATIVE;
BENZIMIDAZOLE DERIVATIVE;
BNIP3 PROTEIN, HUMAN;
BRD4770;
EHMT2 PROTEIN, HUMAN;
GOSSYPOL;
HISTOCOMPATIBILITY ANTIGEN;
HISTONE LYSINE METHYLTRANSFERASE;
LIGHT CHAIN 3, HUMAN;
MEMBRANE PROTEIN;
MICROTUBULE ASSOCIATED PROTEIN;
ONCOPROTEIN;
PROTEIN P53;
TP53 PROTEIN, HUMAN;
ANTAGONISTS AND INHIBITORS;
AUTOPHAGY;
DRUG EFFECTS;
DRUG POTENTIATION;
DRUG RESISTANCE;
DRUG SCREENING;
GENE EXPRESSION;
GENETICS;
HUMAN;
METABOLISM;
PANCREAS TUMOR;
PHAGOSOME;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
AUTOPHAGY;
BENZAMIDES;
BENZIMIDAZOLES;
CELL LINE, TUMOR;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUG SYNERGISM;
GENE EXPRESSION;
GOSSYPOL;
HISTOCOMPATIBILITY ANTIGENS;
HISTONE-LYSINE N-METHYLTRANSFERASE;
HUMANS;
MEMBRANE PROTEINS;
MICROTUBULE-ASSOCIATED PROTEINS;
PANCREATIC NEOPLASMS;
PHAGOSOMES;
PROTO-ONCOGENE PROTEINS;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 84886927142
PISSN: None
EISSN: 20414889
Source Type: Journal
DOI: 10.1038/cddis.2013.191 Document Type: Article |
Times cited : (91)
|
References (0)
|